{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:09:56Z","timestamp":1790665796212,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-154294"],"award-info":[{"award-number":["FDN-154294"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJY-159710"],"award-info":[{"award-number":["PJY-159710"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Variation in CYP2A6, the primary enzyme responsible for nicotine metabolism, is associated with nicotine dependence, cigarette consumption, and abstinence outcomes in smokers. The impact of CYP2A6 activity on nicotine reinforcement and tobacco cue-reactivity, mechanisms that may contribute to these previous associations, has not been fully evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aims and Methods<\/jats:title>\n                  <jats:p>CYP2A6 activity was indexed using 3 genetic approaches in 104 daily smokers completing forced-choice and cue-induced craving tasks assessing nicotine reinforcement and tobacco cue-reactivity, respectively. First, smokers were stratified by the presence or absence of reduced\/loss-of-function CYP2A6 gene variants (normal vs. reduced metabolizers). As nicotine metabolite ratio (NMR) is a reliable biomarker of CYP2A6 activity, our second and third approaches used additional genetic variants identified in genome-wide association studies of NMR to create a weighted genetic risk score (wGRS) to stratify smokers (fast vs. slow metabolizers) and calculate a wGRS-derived NMR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Controlling for race and sex, normal metabolizers (vs. reduced) selected a greater proportion of puffs from nicotine-containing cigarettes (vs. denicotinized) on the forced-choice task (p = .031). In confirmatory analyses, wGRS-based stratification (fast vs. slow metabolizers) produced similar findings. Additionally, wGRS-derived NMR, which correlated with actual NMR assessed in a subset of participants (n = 55), was positively associated with the proportion of puffs from nicotine-containing cigarettes controlling for race and sex (p = .015). None of the CYP2A6 indices were associated with tobacco cue-reactivity in minimally deprived smokers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Findings suggest increased nicotine reinforcement is exhibited by smokers with high CYP2A6 activity, which may contribute to heavier smoking and poorer cessation outcomes previously reported in faster metabolizers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications<\/jats:title>\n                  <jats:p>CYP2A6 activity is a key determinant of smoking behavior and outcomes. Therefore, these findings support the targeting of CYP2A6 activity, either therapeutically or as a clinically relevant biomarker in a precision medicine approach, for tobacco use disorder treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ntr\/ntab064","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T19:09:53Z","timestamp":1617390593000},"page":"1735-1743","source":"Crossref","is-referenced-by-count":18,"title":["Impact of CYP2A6 Activity on Nicotine Reinforcement and Cue-Reactivity in Daily Smokers"],"prefix":"10.1093","volume":"23","author":[{"given":"Kevin","family":"Butler","sequence":"first","affiliation":[{"name":"Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan J","family":"Chenoweth","sequence":"additional","affiliation":[{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"El-Boraie","sequence":"additional","affiliation":[{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidy","family":"Giratallah","sequence":"additional","affiliation":[{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Kowalczyk","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD, USA"},{"name":"Department of Psychology, Hartwick College, Oneonta, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Heishman","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel F","family":"Tyndale","sequence":"additional","affiliation":[{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[{"name":"Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, ON, Canada"},{"name":"Acute Care Program, Centre for Addiction and Mental Health, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,5]]},"reference":[{"key":"2021082906110987700_CIT0001","author":"World Health Organization"},{"issue":"4","key":"2021082906110987700_CIT0002","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/ntr\/ntz038","article-title":"Tobacco cost of illness studies: a systematic review","volume":"22","author":"Makate","year":"2020","journal-title":"Nicotine Tob Res."},{"issue":"5","key":"2021082906110987700_CIT0003","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/add.14549","article-title":"Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation","volume":"114","author":"Jackson","year":"2019","journal-title":"Addiction."},{"issue":"1","key":"2021082906110987700_CIT0004","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clpt.2004.02.011","article-title":"Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity","volume":"76","author":"Dempsey","year":"2004","journal-title":"Clin Pharmacol Ther."},{"issue":"9","key":"2021082906110987700_CIT0005","doi-asserted-by":"crossref","first-page":"e1005498","DOI":"10.1371\/journal.pgen.1005498","article-title":"A genome-wide association study of a biomarker of nicotine metabolism","volume":"11","author":"Loukola","year":"2015","journal-title":"PLoS Genet."},{"key":"2021082906110987700_CIT0006","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-020-0702-z","article-title":"Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent [published online ahead of print March 10, 2020]","author":"Buchwald","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"3","key":"2021082906110987700_CIT0007","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/add.14032","article-title":"Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences","volume":"113","author":"Chenoweth","year":"2018","journal-title":"Addiction."},{"issue":"2","key":"2021082906110987700_CIT0008","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/pgs.15.156","article-title":"CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms","volume":"17","author":"Wassenaar","year":"2016","journal-title":"Pharmacogenomics."},{"issue":"5","key":"2021082906110987700_CIT0009","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/1462220031000158717","article-title":"Nicotine metabolite ratio as a predictor of cigarette consumption","volume":"5","author":"Benowitz","year":"2003","journal-title":"Nicotine Tob Res."},{"key":"2021082906110987700_CIT0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.drugalcdep.2015.01.032","article-title":"Association of CYP2A6 gene polymorphisms with cigarette consumption: a meta-analysis","volume":"149","author":"Pan","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"2021082906110987700_CIT0011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","article-title":"Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use","volume":"51","author":"Liu","year":"2019","journal-title":"Nat Genet."},{"issue":"6687","key":"2021082906110987700_CIT0012","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/31623","article-title":"Nicotine metabolism defect reduces smoking","volume":"393","author":"Pianezza","year":"1998","journal-title":"Nature."},{"issue":"17","key":"2021082906110987700_CIT0013","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/jnci\/djr237","article-title":"Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk","volume":"103","author":"Wassenaar","year":"2011","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"2021082906110987700_CIT0014","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1542\/peds.2006-1583","article-title":"The role of CYP2A6 in the emergence of nicotine dependence in adolescents","volume":"119","author":"Audrain-McGovern","year":"2007","journal-title":"Pediatrics."},{"key":"2021082906110987700_CIT0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.drugalcdep.2015.11.017","article-title":"Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers","volume":"158","author":"Chenoweth","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"2021082906110987700_CIT0016","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/adb.12477","article-title":"CYP2A6 metabolism in the development of smoking behaviors in young adults","volume":"23","author":"Olfson","year":"2018","journal-title":"Addict Biol."},{"issue":"4","key":"2021082906110987700_CIT0017","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/FPC.0b013e32835f834d","article-title":"CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers","volume":"23","author":"Chenoweth","year":"2013","journal-title":"Pharmacogenet Genomics."},{"issue":"1","key":"2021082906110987700_CIT0018","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pbb.2008.10.016","article-title":"Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study","volume":"92","author":"Schnoll","year":"2009","journal-title":"Pharmacol Biochem Behav."},{"issue":"6","key":"2021082906110987700_CIT0019","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.clpt.2006.02.006","article-title":"Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation","volume":"79","author":"Lerman","year":"2006","journal-title":"Clin Pharmacol Ther."},{"issue":"2","key":"2021082906110987700_CIT0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir Med."},{"issue":"24","key":"2021082906110987700_CIT0021","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra0809890","article-title":"Nicotine addiction","volume":"362","author":"Benowitz","year":"2010","journal-title":"N Engl J Med."},{"issue":"2","key":"2021082906110987700_CIT0022","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1371\/journal.pone.0000230","article-title":"High reinforcing efficacy of nicotine in non-human primates","volume":"2","author":"Le Foll","year":"2007","journal-title":"PLoS One."},{"issue":"6","key":"2021082906110987700_CIT0023","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/npp.2011.336","article-title":"Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine","volume":"37","author":"Sofuoglu","year":"2012","journal-title":"Neuropsychopharmacology."},{"issue":"8","key":"2021082906110987700_CIT0024","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/ntr\/ntz210","article-title":"Effects of nicotine metabolic rate on cigarette reinforcement","volume":"22","author":"Liakoni","year":"2020","journal-title":"Nicotine Tob Res."},{"issue":"3","key":"2021082906110987700_CIT0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cpt.1238","article-title":"Effects of nicotine metabolic rate on withdrawal symptoms and response to cigarette smoking after abstinence","volume":"105","author":"Liakoni","year":"2019","journal-title":"Clin Pharmacol Ther."},{"issue":"1","key":"2021082906110987700_CIT0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1124\/jpet.119.260653","article-title":"The novel CYP2A6 inhibitor, DLCI-1, decreases nicotine self-administration in mice","volume":"372","author":"Chen","year":"2020","journal-title":"J Pharmacol Exp Ther."},{"issue":"1","key":"2021082906110987700_CIT0027","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mcp.2000.107651","article-title":"Inhibition of cytochrome P450 2A6 increases nicotine\u2019s oral bioavailability and decreases smoking","volume":"68","author":"Sellers","year":"2000","journal-title":"Clin Pharmacol Ther."},{"issue":"3","key":"2021082906110987700_CIT0028","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jsat.2008.06.005","article-title":"The relevance and treatment of cue-induced cravings in tobacco dependence","volume":"36","author":"Ferguson","year":"2009","journal-title":"J Subst Abuse Treat."},{"issue":"4","key":"2021082906110987700_CIT0029","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.neuroimage.2012.01.119","article-title":"Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI","volume":"60","author":"Tang","year":"2012","journal-title":"Neuroimage."},{"issue":"3","key":"2021082906110987700_CIT0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biopsych.2015.11.015","article-title":"Brain responses to smoking cues differ based on nicotine metabolism rate","volume":"80","author":"Falcone","year":"2016","journal-title":"Biol Psychiatry."},{"issue":"1","key":"2021082906110987700_CIT0031","doi-asserted-by":"crossref","first-page":"e12741","DOI":"10.1111\/adb.12741","article-title":"Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity","volume":"25","author":"El-Boraie","year":"2020","journal-title":"Addict Biol."},{"key":"2021082906110987700_CIT0032","article-title":"Transferability of ancestry-specific and cross-ancestry CYP2A6 activity genetic risk scores in African and European populations [published online ahead of print December 9, 2020]","author":"El-Boraie","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2021082906110987700_CIT0033","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1038\/s41598-020-60940-4","article-title":"Exploring the role of the Ser9Gly (rs6280) Dopamine D3 receptor polymorphism in nicotine reinforcement and cue-elicited craving","volume":"10","author":"Chukwueke","year":"2020","journal-title":"Sci Rep."},{"issue":"2","key":"2021082906110987700_CIT0034","doi-asserted-by":"crossref","first-page":"e01982","DOI":"10.1002\/brb3.1982","article-title":"The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue-reactivity, in human smokers","volume":"11","author":"Chukwueke","year":"2021","journal-title":"Brain Behav."},{"issue":"2&3","key":"2021082906110987700_CIT0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/FBP.0000000000000607","article-title":"Significant association of nicotine reinforcement and cue reactivity: a translational study in humans and rats","volume":"32","author":"Butler","year":"2021","journal-title":"Behav Pharmacol."},{"issue":"9","key":"2021082906110987700_CIT0036","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict."},{"issue":"5\u20136","key":"2021082906110987700_CIT0037","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/FBP.0b013e3283641c3d","article-title":"A review of human drug self-administration procedures","volume":"24","author":"Jones","year":"2013","journal-title":"Behav Pharmacol."},{"issue":"1","key":"2021082906110987700_CIT0038","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0306-4603(88)90031-7","article-title":"Smoking topography and nicotine blood levels","volume":"13","author":"Hatsukami","year":"1988","journal-title":"Addict Behav."},{"issue":"2","key":"2021082906110987700_CIT0039","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1521-0391.2011.00203.x","article-title":"Smoking cue reactivity in adult smokers with and without depression: a pilot study","volume":"21","author":"Weinberger","year":"2012","journal-title":"Am J Addict."},{"issue":"4","key":"2021082906110987700_CIT0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/14622200801908174","article-title":"Reliability and validity of a Short Form of the Tobacco Craving Questionnaire","volume":"10","author":"Heishman","year":"2008","journal-title":"Nicotine Tob Res."},{"key":"2021082906110987700_CIT0041","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.dib.2015.10.019","article-title":"Dataset for genotyping validation of cytochrome P450 2A6 whole-gene deletion (CYP2A6*4) by real-time polymerase chain reaction platforms","volume":"5","author":"Shimizu","year":"2015","journal-title":"Data Brief."},{"issue":"8","key":"2021082906110987700_CIT0042","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1158\/1055-9965.EPI-14-1381","article-title":"Nicotine metabolite ratio (3-hydroxycotinine\/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation","volume":"24","author":"Tanner","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"1","key":"2021082906110987700_CIT0043","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1021\/acs.chemrestox.6b00387","article-title":"Nicotine metabolism and smoking: ethnic differences in the role of P450 2A6","volume":"30","author":"Murphy","year":"2017","journal-title":"Chem Res Toxicol."},{"issue":"11","key":"2021082906110987700_CIT0044","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1089\/jwh.2016.6317","article-title":"Sex\/gender differences in cotinine levels among daily smokers in the Pennsylvania Adult Smoking Study","volume":"26","author":"Chen","year":"2017","journal-title":"J Womens Health (Larchmt)."},{"issue":"2","key":"2021082906110987700_CIT0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00213-002-1168-1","article-title":"Sex differences in the subjective and reinforcing effects of cigarette nicotine dose","volume":"163","author":"Perkins","year":"2002","journal-title":"Psychopharmacology (Berl)."},{"issue":"1","key":"2021082906110987700_CIT0046","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5395\/rde.2013.38.1.52","article-title":"Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis","volume":"38","author":"Kim","year":"2013","journal-title":"Restor Dent Endod."},{"issue":"1","key":"2021082906110987700_CIT0047","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40429-015-0042-2","article-title":"Nicotinic receptor contributions to smoking: insights from human studies and animal models","volume":"2","author":"Brunzell","year":"2015","journal-title":"Curr Addict Rep."},{"issue":"11","key":"2021082906110987700_CIT0048","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2967\/jnumed.115.155002","article-title":"Decreased nicotinic receptor availability in smokers with slow rates of nicotine metabolism","volume":"56","author":"Dubroff","year":"2015","journal-title":"J Nucl Med."},{"issue":"7","key":"2021082906110987700_CIT0049","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biopsych.2016.09.013","article-title":"CYP2A6 genetic variation alters striatal-cingulate circuits, network hubs, and executive processing in smokers","volume":"81","author":"Li","year":"2017","journal-title":"Biol Psychiatry."},{"issue":"7","key":"2021082906110987700_CIT0050","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.biopsych.2010.07.014","article-title":"Incubation of cue-induced cigarette craving during abstinence in human smokers","volume":"69","author":"Bedi","year":"2011","journal-title":"Biol Psychiatry."},{"issue":"1","key":"2021082906110987700_CIT0051","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tips.2016.09.006","article-title":"Pharmacogenetic optimization of smoking cessation treatment","volume":"38","author":"Chenoweth","year":"2017","journal-title":"Trends Pharmacol Sci."}],"container-title":["Nicotine &amp; Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ntr\/advance-article-pdf\/doi\/10.1093\/ntr\/ntab064\/38498464\/ntab064.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/23\/10\/1735\/40080204\/ntab064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/23\/10\/1735\/40080204\/ntab064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T06:12:53Z","timestamp":1630217573000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/23\/10\/1735\/6211142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,5]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,4,5]]},"published-print":{"date-parts":[[2021,8,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntab064","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,4,5]]}}}